170 related articles for article (PubMed ID: 38037859)
1. m6A-related lncRNAs as potential biomarkers and the lncRNA ELFN1-AS1/miR-182-5p/BCL-2 regulatory axis in diffuse large B-cell lymphoma.
Yang Q; Lu Y; Du A
J Cell Mol Med; 2024 Jan; 28(2):e18046. PubMed ID: 38037859
[TBL] [Abstract][Full Text] [Related]
2. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression.
Zhao F; Li S; Liu J; Wang J; Yang B
Hum Cell; 2022 Jul; 35(4):1234-1247. PubMed ID: 35676608
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.
Du A; Yang Q; Luo X
Am J Cancer Res; 2023; 13(9):3921-3940. PubMed ID: 37818049
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
6. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
Zhang C; Lian H; Xie L; Yin N; Cui Y
Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685
[TBL] [Abstract][Full Text] [Related]
8. Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML.
Liu M; Yu B; Tian Y; Li F
BMC Cancer; 2024 Jan; 24(1):98. PubMed ID: 38233760
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA ELFN1-AS1 Promoted Colon Cancer Cell Growth and Migration
Du Y; Hou Y; Shi Y; Liu J; Li T
Front Oncol; 2020; 10():588360. PubMed ID: 33634016
[TBL] [Abstract][Full Text] [Related]
10. lncRNA ELFN1-AS1 predicts poor prognosis and promotes tumor progression of non-small cell lung cancer by sponging miR-497.
Yang B; Miao S
Cancer Biomark; 2022; 34(4):637-646. PubMed ID: 35431233
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
[TBL] [Abstract][Full Text] [Related]
12. m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients.
Xu C; He T; Shao X; Gao L; Cao L
Front Oncol; 2022; 12():920023. PubMed ID: 36119534
[TBL] [Abstract][Full Text] [Related]
13. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma.
Zhou X; Zhang H; Duan Y; Zhu J; Dai H
J Clin Lab Anal; 2023 Jan; 37(1):e24813. PubMed ID: 36525280
[TBL] [Abstract][Full Text] [Related]
14. lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.
Huang J; Yuan W; Chen B; Li G; Chen X
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(3):484-497. PubMed ID: 36876422
[TBL] [Abstract][Full Text] [Related]
15. A long non-coding RNA, ELFN1-AS1, sponges miR-1250 to upregulate MTA1 to promote cell proliferation, migration and invasion, and induce apoptosis in colorectal cancer.
Zhai LQ; Wang XX; Qu CX; Yang LZ; Jia CM; Shi XC
Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4655-4667. PubMed ID: 34337713
[TBL] [Abstract][Full Text] [Related]
16. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis.
Lei R; Feng L; Hong D
Cancer Biomark; 2020; 27(4):433-443. PubMed ID: 31929141
[TBL] [Abstract][Full Text] [Related]
17. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Wu J; Cai Y; Zhao G; Li M
J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of the long non-coding RNA CACNA1G-AS1 enhances cytotoxicity and apoptosis of human diffuse large B cell lymphoma by regulating miR-3160-5p.
Zhou Q; Zhang Y; Zhao M; Zhao X; Xue H; Xiao S
Exp Ther Med; 2022 Oct; 24(4):627. PubMed ID: 36160896
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
